查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600142

海洋衍生藥品市場：按來源、藥物類型和最終用戶分類 - 2025-2030 年全球預測

Marine Derived Drugs Market by Source (Algae, Invertebrates, Microorganisms), Drug Type (Analgesics, Anti-coagulants, Anti-inflammatory), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年海洋藥物市場價值為41億美元，預計到2024年將達到44.4億美元，複合年成長率為8.70%，到2030年將達到73.6億美元。

海洋源藥物指從藻類、細菌、真菌、海綿、軟體動物等海洋生物中提取或合成的藥物。這些藥物涵蓋廣泛的治療應用，包括治療癌症、感染疾病、心血管疾病和發炎。對海洋藥物的需求在於其獨特的生物活性化合物，這些化合物通常具有陸地生物中未發現的新穎作用機制。這些藥物在製藥和生物技術領域都有應用，最終用途包括醫院、研究機構和藥品製造商。

主要市場統計
基準年[2023] 41億美元
預測年份 [2024] 44.4億美元
預測年份 [2030] 73.6億美元
複合年成長率（%） 8.70%

海洋藥物市場受到海洋生物技術進步、海洋生物多樣性研究資金增加以及對新療法的需求迅速增加等因素的影響。慢性病盛行率的上升以及人們對海洋生物產品益處的認知不斷增強，進一步推動了市場的成長。最近的商業機會包括審查未開發的海洋棲息地、促進學術界和工業界之間的合作以及開發永續的提取技術。然而，挑戰包括嚴格的法律規範、高昂的研發成本以及環境保護工作的不確定性。監管機構被要求透過簡化流程和促進永續實踐，將環境保護工作與藥物開發結合。

未發現的海洋生物的生物探勘、改進藥物輸送系統以及合成受海洋啟發的類似物等領域存在大量創新機會。專注於基因組學和代謝體學的富有洞察力的研究可以揭示複雜的海洋生物系統，並增加突破性藥物發現的潛力。市場的本質是高度動態的，並由科學探索和商業性可行性相結合所驅動。希望在這一領域發展的公司可以透過投資跨學科研究、利用人工智慧進行資料分析以及充分利用全球研究合作來克服限制並獲得該領域所需的專業知識。

市場動態：揭示快速發展的海洋衍生藥品市場的關鍵市場洞察

供需的動態交互作用正在改變海洋藥品市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 世界各地慢性病的盛行率
    • 政府和私營部門增加對海洋生物技術的投資
  • 市場限制因素
    • 海洋資源相關新藥開發成本高
  • 市場機會
    • 海洋藥物萃取和合成技術的不斷進步
    • 人們越來越關注擴大海洋藥物的治療潛力
  • 市場問題
    • 有關海洋藥物的環境和倫理問題

波特五力：駕馭海洋衍生藥物市場的戰略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解外部對海洋藥物市場的影響

外部宏觀環境因素在塑造海洋藥物市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解海洋藥物市場的競爭格局

對海洋衍生藥品市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：海洋衍生藥品市場供應商的績效評估

FPNV定位矩陣是評估海洋衍生藥品市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃海洋藥物市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對海洋藥品市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、核准核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的慢性病盛行率正在上升
      • 增加政府和私人對海洋生物技術的投資
    • 抑制因素
      • 海洋資源相關新藥開發成本高
    • 機會
      • 海洋藥物萃取與合成技術發展
      • 擴大海洋藥物的治療潛力正引起越來越多的關注
    • 任務
      • 有關海洋藥物的環境和倫理問題
  • 市場區隔分析
    • 來源：藻類的使用增加，尤其是在護膚品中
    • 最終用戶：經監管部門核准，各醫院海洋源藥物的巨大潛力
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 海洋藥物市場：依來源分類

  • 介紹
  • 藻類
  • 無脊椎動物
  • 微生物

第7章 海洋藥物市場：依藥物類型

  • 介紹
  • 止痛藥
  • 抗凝血物
  • 發炎（藥
  • 抗菌的
  • 抗病毒藥
  • 抗癌藥

第8章 海洋藥物市場：依最終使用者分類

  • 介紹
  • 醫院
  • 製藥和生物技術公司
  • 研究/學術機構

第9章 美洲海洋藥物市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太海洋衍生藥品市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的海洋藥物市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 加州大學聖地牙哥分校開發基於藻類的微型機器人技術，以增強肺部腫瘤的藥物輸送
    • GITAM 獲得 136.9 億印度盧比用於創新海洋藥物發現中心，以對抗癌症和抗生素抗藥性
  • 戰略分析和建議

公司名單

  • Aker BioMarine ASA
  • Aphios Corporation
  • Eisai Co., Ltd.
  • Gimv NV
  • GlycoMar Limited
  • Marinova Pty Ltd.
  • Nereus Pharmaceuticals, Inc.
  • Perha Pharmaceuticals
  • Pfizer, Inc.
  • Pharma Mar, SA
  • TransAlgae
  • Zelnova Zeltia
Product Code: MRR-437A48C79EDF

The Marine Derived Drugs Market was valued at USD 4.10 billion in 2023, expected to reach USD 4.44 billion in 2024, and is projected to grow at a CAGR of 8.70%, to USD 7.36 billion by 2030.

Marine-derived drugs refer to pharmaceuticals that are extracted or synthesized from marine organisms, such as algae, bacteria, fungi, sponges, and mollusks. The scope of these drugs encompasses a wide range of therapeutic applications, including treatments for cancer, infections, cardiovascular diseases, and inflammation. The necessity for marine-derived drugs is driven by their unique bioactive compounds, which often offer novel mechanisms of action not found in terrestrial organisms. These drugs are applied in both pharmaceutical and biotechnology settings, with end-use scope including hospitals, research institutions, and pharmaceutical manufacturers.

KEY MARKET STATISTICS
Base Year [2023] USD 4.10 billion
Estimated Year [2024] USD 4.44 billion
Forecast Year [2030] USD 7.36 billion
CAGR (%) 8.70%

The market for marine-derived drugs is influenced by factors such as technological advancements in marine biotechnology, increased funding for marine biodiversity research, and a surge in demand for novel therapeutics. The rising incidence of chronic diseases and the growing awareness of the benefits of marine bioproducts further bolster market growth. Recent opportunities lie in the in-depth exploration of uncharted marine habitats, fostering collaborations partnerships between academia and industry, and the development of sustainable harvesting techniques. However, challenges include stringent regulatory frameworks, high research and development costs, and uncertainties related to environmental conservation efforts. There's a need for regulatory bodies to streamline processes and promote sustainable practices, aligning conservation efforts with pharmaceutical development.

Innovation opportunities abound in areas such as bioprospecting for undiscovered marine organisms, the improvement of drug delivery systems, and the synthesis of marine-inspired analogs. Insightful research can focus on genomics and metabolomics to unravel complex marine biosystems, advancing the potential for groundbreaking drug discoveries. The nature of the market is highly dynamic, driven by a combination of scientific inquiry and commercial viability. Companies aiming to grow in this space should invest in cross-disciplinary research, leverage artificial intelligence for data analysis, and engage in global collaborations to overcome limitations and maximize the expertise required in the field.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Marine Derived Drugs Market

The Marine Derived Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases worldwide
    • Growing investments in marine biotechnologies by government and private authorities
  • Market Restraints
    • High cost of development of new drugs associated with marine sources
  • Market Opportunities
    • Increasing advances in extraction and synthesis technologies of marine derived drugs
    • Growing focus on expanding therapeutic potential of marine-derived drugs
  • Market Challenges
    • Environmental and ethical concerns with marine derived drugs

Porter's Five Forces: A Strategic Tool for Navigating the Marine Derived Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Marine Derived Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Marine Derived Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Marine Derived Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Marine Derived Drugs Market

A detailed market share analysis in the Marine Derived Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Marine Derived Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Marine Derived Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Marine Derived Drugs Market

A strategic analysis of the Marine Derived Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Marine Derived Drugs Market, highlighting leading vendors and their innovative profiles. These include Aker BioMarine ASA, Aphios Corporation, Eisai Co., Ltd., Gimv NV, GlycoMar Limited, Marinova Pty Ltd., Nereus Pharmaceuticals, Inc., Perha Pharmaceuticals, Pfizer, Inc., Pharma Mar, S.A., TransAlgae, and Zelnova Zeltia.

Market Segmentation & Coverage

This research report categorizes the Marine Derived Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Source, market is studied across Algae, Invertebrates, and Microorganisms.
  • Based on Drug Type, market is studied across Analgesics, Anti-coagulants, Anti-inflammatory, Anti-microbial, Anti-viral, and Anticancer.
  • Based on End-User, market is studied across Hospitals, Pharmaceutical & Biotechnology Companies, and Research & Academic Institutions.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases worldwide
      • 5.1.1.2. Growing investments in marine biotechnologies by government and private authorities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of new drugs associated with marine sources
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing advances in extraction and synthesis technologies of marine derived drugs
      • 5.1.3.2. Growing focus on expanding therapeutic potential of marine-derived drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Environmental and ethical concerns with marine derived drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Source: Growing usage of algae especially in skincare products
    • 5.2.2. End-User: High potential of marine derived drugs across hospitals that have obtained regulatory approvals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Marine Derived Drugs Market, by Source

  • 6.1. Introduction
  • 6.2. Algae
  • 6.3. Invertebrates
  • 6.4. Microorganisms

7. Marine Derived Drugs Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Analgesics
  • 7.3. Anti-coagulants
  • 7.4. Anti-inflammatory
  • 7.5. Anti-microbial
  • 7.6. Anti-viral
  • 7.7. Anticancer

8. Marine Derived Drugs Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Research & Academic Institutions

9. Americas Marine Derived Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Marine Derived Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Marine Derived Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. UC San Diego Innovates Algae-Based Microbot Technology for Enhanced Lung Tumor Drug Delivery
    • 12.3.2. GITAM secures INR 13.69 crore for innovative marine drug discovery center to combat cancer and antibiotic resistance
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aker BioMarine ASA
  • 2. Aphios Corporation
  • 3. Eisai Co., Ltd.
  • 4. Gimv NV
  • 5. GlycoMar Limited
  • 6. Marinova Pty Ltd.
  • 7. Nereus Pharmaceuticals, Inc.
  • 8. Perha Pharmaceuticals
  • 9. Pfizer, Inc.
  • 10. Pharma Mar, S.A.
  • 11. TransAlgae
  • 12. Zelnova Zeltia

LIST OF FIGURES

  • FIGURE 1. MARINE DERIVED DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. MARINE DERIVED DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MARINE DERIVED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MARINE DERIVED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MARINE DERIVED DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MARINE DERIVED DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ALGAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY INVERTEBRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MICROORGANISMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-COAGULANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-MICROBIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-VIRAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. MARINE DERIVED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. MARINE DERIVED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023